|
|
| | Carfilzomib Impurity 65 Basic information |
| Product Name: | Carfilzomib Impurity 65 | | Synonyms: | Carfilzomib Impurity 65;Carbamic acid, N-[(1R)-3-methyl-1-(2-methylpropyl)-2-oxo-3-buten-1-yl]-, 1,1-dimethylethyl ester;tert-Butyl (R)-(2,6-dimethyl-3-oxohept-1-en-4-yl)carbamate;(R)-(2,6-Dimethyl-3-oxohept-1-en-4-yl) tert-butyl carbamate;tert-Butyl (R)-(2,6-dimethyl-3-oxohept-1-en-4-yl)carbamate
Carfilzomib Impurity 65 | | CAS: | 2177287-70-4 | | MF: | C14H25NO3 | | MW: | 255.35 | | EINECS: | | | Product Categories: | | | Mol File: | 2177287-70-4.mol |  |
| | Carfilzomib Impurity 65 Chemical Properties |
| Boiling point | 350.4±25.0 °C(Predicted) | | density | 0.964±0.06 g/cm3(Predicted) | | pka | 11.05±0.46(Predicted) |
| | Carfilzomib Impurity 65 Usage And Synthesis |
| Uses | (R)-t-Butyl (2,6-Dimethyl-3-oxohept-1-en-4-yl)carbamate is an intermediate in synthesizing (R)-2-Amino-4-methyl-1-((S)-2-methyloxiran-2-yl)pentan-1-one Trifluoroacetate Salt (A605100), an impurity of carfilzomib (C183460). Carfilzomib is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma. |
| | Carfilzomib Impurity 65 Preparation Products And Raw materials |
|